Canton Strategic Holdings (CNTN) Payables (2020 - 2026)
Canton Strategic Holdings (CNTN) reported Payables of $402311.0 for Q1 2026, down 63.74% on a YoY basis from $1.1 million in Q1 2025, and down 63.1% quarter-over-quarter from $1.1 million in Q4 2025.
Canton Strategic Holdings (CNTN) Payables (2020 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Payables for 7 years, with the latest figure at $402311.0 in Q1 2026.
- For the quarter ending Q1 2026, Payables fell 63.74% year-over-year to $402311.0; the trailing twelve-month figure through Mar 2026 stood at $402311.0 (down 63.74% YoY), and the FY2025 full-year result was $1.1 million, changed 0.06% from the prior year.
- Payables for Q1 2026 stood at $402311.0, down from $1.1 million in the prior quarter.
- The five-year high for Payables was $1.1 million in Q2 2023, with the low at $402311.0 in Q1 2026.
- Historically, Payables has averaged $861688.4 across 5 years, with a median of $908577.0 in 2023.
- Annual changes were most pronounced in 2022 — Payables tumbled 66.57% — and 2023, when it jumped 112.11%.
- Canton Strategic Holdings' Payables stood at $954505.0 in 2022, then fell by 4.81% to $908577.0 in 2023, then gained by 19.93% to $1.1 million in 2024, then climbed by 0.06% to $1.1 million in 2025, then plunged by 63.1% to $402311.0 in 2026.
- The last three Payables figures came in at $402311.0 (Q1 2026), $1.1 million (Q4 2025), and $820371.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | 402,311.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 402,311.00 |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 820,371.00 |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | 783,839.00 |
| Jun 30, 2024 | 784,029.00 |
| Mar 31, 2024 | 993,244.00 |
| Dec 31, 2023 | 908,577.00 |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 718,990.00 |
| Dec 31, 2022 | 954,505.00 |
| Sep 30, 2022 | 536,838.00 |
| Jun 30, 2022 | 559,529.00 |
| Mar 31, 2022 | 597,455.00 |
| Dec 31, 2021 | 2.86 Mn |
| Dec 31, 2020 | 1.08 Mn |